Professor Carlo di Mario

Publications


Journals

  • Wykrzykowska JJ; Garg S; Onuma Y; de Vries T; Morel M-A; van Es G-A; Buszman P; Linke A; et alIschinger T; Klauss V; Corti R; Eberli F; Wijns W; Morice M-C; Di Mario C; van Geuns RJ; Juni P; Windecker S; Serruys PW. (1 Sep 2011). Implantation of the biodegradable polymer biolimus-eluting stent in patients with high SYNTAX score is associated with decreased cardiac mortality compared to a permanent polymer sirolimus-eluting stent: two year follow-up results from the "all-comers" LEADERS trial. EUROINTERVENTION. 7:605-613. Author weblink.
  • Secco GG; Foin N; Viceconte N; Borgia F; De Luca G; Di Mario C. (Nov 2011). Optical coherence tomography for guidance of treatment of in-stent restenosis with cutting balloons. EuroIntervention. 7:828-834. DOI.
  • Chan PH; Di Mario C; Franzen O. (8 Mar 2012). Dissociation between anatomical and functional results after MitraClip implantation. Int J Cardiol. 155:175-176. DOI.
  • Chan PH; Di Mario C; Davies SW; Kelleher A; Trimlett R; Moat N. (11 Oct 2011). Transcatheter Aortic Valve Implantation in Degenerate Failing Aortic Homograft Root Replacements. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 58:1729-1730. Author weblink DOI.
  • Claessen BE; Dangas GD; Godino C; Lee S-W; Obunai K; Carlino M; Suh J-W; Leon MB; et alDi Mario C; Park S-J; Stone GW; Moses JW; Colombo A; Mehran R. (1 Oct 2011). Long-Term Clinical Outcomes of Percutaneous Coronary Intervention for Chronic Total Occlusions in Patients With Versus Without Diabetes Mellitus. AMERICAN JOURNAL OF CARDIOLOGY. 108:924-931. Author weblink DOI.
  • Gutierrez-Chico JL; van Geuns RJ; Regar E; van der Giessen WJ; Kelbaek H; Saunamaki K; Escaned J; Gonzalo N; et aldi Mario C; Borgia F; Nueesch E; Garcia-Garcia HM; Silber S; Windecker S; Serruys PW. (1 Oct 2011). Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE All Comers trial. EUROPEAN HEART JOURNAL. 32:2454-2463. Author weblink DOI.
  • Mehran R; Claessen BE; Godino C; Dangas GD; Obunai K; Kanwal S; Carlino M; Henriques JPS; et alDi Mario C; Kim Y-H; Park S-J; Stone GW; Leon MB; Moses JW; Colombo A. (1 Sep 2011). Long-Term Outcome of Percutaneous Coronary Intervention for Chronic Total Occlusions. JACC-CARDIOVASCULAR INTERVENTIONS. 4:952-961. Author weblink DOI.
  • Tyczynski P; Ferrante G; Witkowska AB; Lindsay AC; Foin N; Ghilencea L; Viceconte N; Chan M; et alDi Mario C. (1 Sep 2011). Different patterns of stent endothelialization and restenosis at follow-up. Optical coherence tomography observations. POSTEPY W KARDIOLOGII INTERWENCYJNEJ. 7:248-251. Author weblink DOI.
  • Galassi AR; Tomasello SD; Reifart N; Werner GS; Sianos G; Bonnier H; Sievert H; Ehladad S; et alBufe A; Shofer J; Gershlick A; Hildick-Smith D; Escaned J; Erglis A; Sheiban I; Thuesen L; Serra A; Christiansen E; Buettner A; Costanzo L; Barrano G; Di Mario C. (1 Aug 2011). In-hospital outcomes of percutaneous coronary intervention in patients with chronic total occlusion: insights from the ERCTO (European Registry of Chronic Total Occlusion) registry. EUROINTERVENTION. 7:472-479.
  • Di Mario C; Kukreja N. (1 Mar 2009). The CTTO registry: is the CT really necessary?. EUROINTERVENTION. 4:551-+. Author weblink.
  • Di Mario C. (1 Sep 2009). Informed consent in interventional cardiology. EUROINTERVENTION. 5:415-416. Author weblink DOI.
  • Di Mario C; Roffi M. (1 Jun 2011). Peripheral interventions: how long will they remain a missed opportunity?. EUROINTERVENTION. 7:177-+. Author weblink DOI.
  • Ghimire G; Spiro J; Kharbanda R; Roughton M; Barlis P; Mason M; Ilsley C; Di Mario C; et alErbel R; Waksman R; Dalby M. (1 Jan 2009). Initial evidence for the return of coronary vasoreactivity following the absorption of bioabsorbable magnesium alloy coronary stents. EUROINTERVENTION. 4:481-484. Author weblink DOI.
  • Tyczynski P; Ferrante G; Kukreja N; Moreno-Ambroj C; Barlis P; Ramasami N; De Silva R; Beatt K; et alDi Mario C. (1 Nov 2009). Optical coherence tomography assessment of a new dedicated bifurcation stent. EUROINTERVENTION. 5:544-551. Author weblink DOI.
  • Di Mario C. (1 Nov 2009). Interventional cardiologists: a new breed?. EUROINTERVENTION. 5:535-537. Author weblink DOI.
  • Foin N; Secco GG; Ghilencea L; Krams R; Di Mario C. (Sep 2011). Final proximal post-dilatation is necessary after kissing balloon in bifurcation stenting. EuroIntervention. 7:597-604. DOI.
  • Di Mario C. (1 Jul 2011). European interventional cardiology: a global player. EUROINTERVENTION. 7:303-+. Author weblink DOI.
  • Di Mario C; Auricchio A. (1 Apr 2011). Plumbers and electricians: you need both to build a house. EUROINTERVENTION. 6:1033-1035. Author weblink.
  • Garg S; Wykrzykowska J; Serruys PW; de Vries T; Buszman P; Trznadel S; Linke A; Lenk K; et alIschinger T; Klauss V; Eberli F; Corti R; Wijns W; Morice M-C; di Mario C; Tyczynski P; van Geuns RJ; Eerdmans P; van Es G-A; Meier B; Jueni P; Windecker S. (1 Mar 2011). The outcome of bifurcation lesion stenting using a biolimus-eluting stent with a bio-degradable polymer compared to a sirolimus-eluting stent with a durable polymer. EUROINTERVENTION. 6:928-935. Author weblink.
  • Di Mario C. (1 Mar 2011). Differences in the approval process for interventional devices in Europe and USA: IN MEDIO STAT VIRTUS. EUROINTERVENTION. 6:913-+. Author weblink.
  • Di Mario C. (1 Feb 2011). Interventional cardiology: an imaging subspecialty. EUROINTERVENTION. 6:799-+. Author weblink DOI.
  • Di Mario C; Alfieri O; Iung B; Serruys PW. (1 Jan 2011). Transcatheter valves and interventional cardiology. EUROINTERVENTION. 6:673-+. Author weblink DOI.
  • Di Mario C; Iakovou I; van der Giessen WJ; Foin N; Adrianssens T; Tyczynski P; Ghilencea L; Viceconte N; et alLindsay AC. (1 Dec 2010). Optical coherence tomography for guidance in bifurcation lesion treatment. EUROINTERVENTION. 6:J99-J106. Author weblink.
  • Di Mario C. (1 Nov 2010). The Show is Over: time to start preparing the new one. EUROINTERVENTION. 6:555-+. Author weblink DOI.
  • Di Mario C. (1 Sep 2010). Time of elections; time to reflect on the principles informing the government of scientific societies. EUROINTERVENTION. 6:433-+. Author weblink.
  • Di Mario C; Zamorano J. (1 Aug 2010). Hand and brain coordination: new challenges for interventional cardiology and echocardiography. EUROINTERVENTION. 6:309-+. Author weblink.
  • Garg S; Sarno G; Serruys PW; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; et alEberli F; Corti R; Wijns W; Morice M-C; Di Mario C; van Geuns RJ; Eerdmans P; van Es G-A; Meier B; Jueni P; Windecker S. (1 Jun 2010). The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer. EUROINTERVENTION. 6:233-239. Author weblink.
  • Di Mario C; James S; Ludman P; Windecker S; Sabate M. (1 Jun 2010). Scientific societies and clinical trials. EUROINTERVENTION. 6:185-188. Author weblink.
  • Tyczynski P; Kukreja N; van Geuns R-J; Wykrzykowska JJ; Sheppard MN; Di Mario C. (1 May 2010). Optical coherence tomography for the assessment of pericardium covered stents for the treatment of degenerated saphenous vein grafts. EUROINTERVENTION. 6:78-85. Author weblink.
  • Di Mario C; Pugliese F. (1 May 2010). To whom does cardiac MSCT belong?. EUROINTERVENTION. 6:29-+. Author weblink.
  • Godino C; Parodi G; Furuichi S; Latib A; Barbagallo R; Goktekin O; Cera M; Mueller R; et alTamburino C; Grube E; Di Mario C; Reimers B; Chieffo A; Antoniucci D; Colombo A; Sangiorgi GM. (1 Apr 2010). Long-term follow-up (four years) of unprotected left main coronary artery disease treated with paclitaxel-eluting stents (from the TRUE Registry). EUROINTERVENTION. 5:906-916. Author weblink.
  • Di Mario C. (1 Apr 2010). Why so few women in interventional cardiology?. EUROINTERVENTION. 5:883-+. Author weblink.
  • Di Mario C. (1 Feb 2010). Minutes and Handbooks. EUROINTERVENTION. 5:769-772. Author weblink.
  • Klauss V; Serruys PW; Pilgrim T; Buszman P; Linke A; Ischinger T; Eberli F; Corti R; et alWijns W; Morice M-C; di Mario C; van Geuns RJ; van Es G-A; Kalesan B; Wenaweser P; Jueni P; Windecker S. (1 Aug 2011). 2-Year Clinical Follow-Up From the Randomized Comparison of Biolimus-Eluting Stents With Biodegradable Polymer and Sirolimus-Eluting Stents With Durable Polymer in Routine Clinical Practice. JACC-CARDIOVASCULAR INTERVENTIONS. 4:887-895. Author weblink DOI.
  • Di Mario C; Piepoli MF. (1 Jan 2010). "Rehabilitation" after PCI: nonsense or the only way to achieve lasting results?. EUROINTERVENTION. 5:655-658. Author weblink DOI.
  • Lindsay AC; Viceconte N; Di Mario C. (1 Sep 2011). Optical coherence tomography: has its time come?. HEART. 97:1361-1362. Author weblink DOI.
  • Wijns W; Di Mario C. (1 Aug 2009). Presidential Criss-Cross The transfer of office between EAPCI presidents. EUROINTERVENTION. 5:293-+. Author weblink DOI.
  • Wykrzykowska JJ; Raeber L; de Vries T; Bressers M; Buszman P; Linke A; Ischinger T; Klauss V; et alEberli F; Corti R; Wijns W; Morice M-C; di Mario C; Regar E; Jueni P; Windecker S; Serruys PW. (1 Aug 2009). Biolimus-eluting biodegradable polymer versus sirolimuseluting permanent polymer stent performance in long lesions: results from the LEADERS multicentre trial substudy. EUROINTERVENTION. 5:310-317. Author weblink DOI.
  • Barlis P; Gonzalo N; Di Mario C; Prati F; Buellesfeld L; Rieber J; Dalby MC; Ferrante G; et alCera M; Grube E; Serruys PW; Regar E. (1 May 2009). A multicentre evaluation of the safety of intracoronary optical coherence tomography. EUROINTERVENTION. 5:90-95. Author weblink.
  • Di Mario C; Borgia F; Franzen O. (26 Aug 2011). Ventilation manoeuvres facilitate MitraClip placement: the response. Heart. DOI.
  • Gutierrez-Chico JL; Regar E; Nueesch E; Okamura T; Wykrzykowska J; di Mario C; Windecker S; van Es G-A; et alGobbens P; Jueni P; Serruys PW. (2 Aug 2011). Delayed Coverage in Malapposed and Side-Branch Struts With Respect to Well-Apposed Struts in Drug-Eluting Stents In Vivo Assessment With Optical Coherence Tomography. CIRCULATION. 124:612-U192. DOI.
  • Di Mario C; Windecker S; Fajadet J. (Aug 2011). Continuity and innovation: the yin and yang of interventional cardiology. EuroIntervention. 7:425-427. DOI.
  • Lindsay AC; Viceconte N; Di Mario C. (Sep 2011). Optical coherence tomography: has its time come?. Heart. 97:1361-1362. DOI.
  • Di Mario C. (Jul 2011). European interventional cardiology: a global player. EuroIntervention. 7:303-306. DOI.
  • Foin N; Viceconte N; Chan PH; Lindsay AC; Krams R; Di Mario C. (Aug 2011). Jailed side branches: fate of unapposed struts studied with 3D frequency-domain optical coherence tomography. J Cardiovasc Med (Hagerstown). 12:581-582. DOI.
  • Stefanini GG; Serruys PW; Silber S; Khattab AA; van Geuns RJ; Richardt G; Buszman PE; Kelbaek H; et alvan Boven AJ; Hofma SH; Linke A; Klauss V; Wijns W; Macaya C; Garot P; Di Mario C; Manoharan G; Kornowski R; Ischinger T; Bartorelli AL; Gobbens P; Windecker S. (31 May 2011). The Impact of Patient and Lesion Complexity on Clinical and Angiographic Outcomes After Revascularization With Zotarolimus- and Everolimus-Eluting Stents A Substudy of the RESOLUTE All Comers Trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention). JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 57:2221-2232. DOI.
  • Di Mario C; Roffi M. (Jun 2011). Peripheral interventions: how long will they remain a missed opportunity?. EuroIntervention. 7:177-181. DOI.
  • Di Mario C; James S; Dudek D; Sabate M; Degertekin M. (14 May 2011). Commentary: The risk of over-regulation. BRITISH MEDICAL JOURNAL. 342. DOI.
  • Iakovou I; Foin N; Andreou A; Viceconte N; Di Mario C. (1 May 2011). New strategies in the treatment of coronary bifurcations. HERZ. 36:198-212. DOI.
  • Di Mario C. (May 2011). Patrick W. Serruys and the EAPCI. EuroIntervention. 7:35-38. DOI.
  • Borgia F; Di Mario C; Franzen O. (1 May 2011). Adenosine-induced asystole to facilitate MitraClip placement in a patient with adverse mitral valve morphology. HEART. 97:864-864. Author weblink DOI.
  • Di Mario C; Auricchio A. (Apr 2011). Plumbers and electricians: you need both to build a house. EuroIntervention. 6:1033-1035. DOI.
  • Di Mario C; Viceconte N. (23 Apr 2011). Radial angioplasty: worthy RIVAL, not undisputed winner. Lancet. 377:1381-1383. DOI.
  • Tyczynski P; Moreno-Ambroj C; Ghilencea L; Witkowska AB; Di Mario C. (1 Nov 2010). Long term observation of thin-cap fibroatheroma by optical coherence tomography. CARDIOLOGY JOURNAL. 17:634-635.
  • Di Mario C. (Mar 2011). Differences in the approval process for interventional devices in Europe and USA: IN MEDIO STAT VIRTUS. EuroIntervention. 6:913-917. DOI.
  • Secco GG; Di Mario C. (15 Feb 2011). A new dedicated ultrashort steerable balloon for side branch ostial dilatation. Catheter Cardiovasc Interv. 77:363-366. DOI.
  • Di Mario C. (Feb 2011). Interventional cardiology: an imaging subspecialty. EuroIntervention. 6:799-802. DOI.
  • Di Mario C. (1 Feb 2011). Culprit or multivessel treatment for STEMI: the opinion of a repented principal investigator. Catheter Cardiovasc Interv. 77:171-173. DOI.
  • Wykrzykowska JJ; Garg S; Onuma Y; de Vries T; Goedhart D; Morel MA; van Es GA; Buszman P; et alLinke A; Ischinger T; Klauss V; Corti R; Eberli F; Wijns W; Morice MC; di Mario C; van Geuns RJ; Juni P; Windecker S; Serruys PW. (1 Feb 2011). Value of age, creatinine, and ejection fraction (ACEF score) in assessing risk in patients undergoing percutaneous coronary interventions in the 'All-Comers' LEADERS trial. Circ Cardiovasc Interv. 4:47-56. DOI.
  • Di Mario C; Alfieri O; Iung B; Serruys PW. (Jan 2011). Transcatheter valves and interventional cardiology. EuroIntervention. 6:673-677. DOI.
  • Wilkinson E; Di Mario C. (1 Jan 2011). Working and living abroad, from Italy to England via Holland. EUROPEAN HEART JOURNAL. 32:6-7. Author weblink.
  • Di Mario C; Boehm M; Dudek D; Eeckhout E; Roffi M. (Nov 2010). The Show is Over: time to start preparing the new one. EuroIntervention. 6:555-559. DOI.
  • Dimopoulos K; Dudek D; Piscione F; Mielecki W; Savonitto S; Borgia F; Murena E; Manari A; et alGaspardone A; Ochala A; Zmudka K; Bolognese L; Steg PG; Flather M; Di Mario C; CARESS-in-AMI (Combined Abciximab RE-teplase Stent Study in Acute Myocardial Infarction) Investigators. (9 Feb 2012). Timing of events in STEMI patients treated with immediate PCI or standard medical therapy: implications on optimisation of timing of treatment from the CARESS-in-AMI trial. Int J Cardiol. 154:275-281. DOI.
  • Kumar S; Gorog DA; Secco GG; Di Mario C; Kukreja N. (Oct 2010). The GuideLiner "child" catheter for percutaneous coronary intervention - early clinical experience. J Invasive Cardiol. 22:495-498.
  • Locca D; Bucciarelli-Ducci C; Ferrante G; La Manna A; Keenan NG; Grasso A; Barlis P; Del Furia F; et alPrasad SK; Kaski JC; Pennell DJ; Di Mario C. (Sep 2010). New universal definition of myocardial infarction applicable after complex percutaneous coronary interventions?. JACC Cardiovasc Interv. 3:950-958. DOI.
  • Di Mario C. (Sep 2010). Time of elections; time to reflect on the principles informing the government of scientific societies. EuroIntervention. 6:433-436. DOI.
  • Ferrante G; Pugliese F; Di Mario C. (4 Sep 2010). Jugular venous pressure: a cardinal sign. Lancet. 376:802. DOI.
  • Tyczynski P; Ferrante G; Moreno-Ambroj C; Kukreja N; Barlis P; Pieri E; De Silva R; Beatt K; et alDi Mario C. (1 Aug 2010). Simple Versus Complex Approaches to Treating Coronary Bifurcation Lesions: Direct Assessment of Stent Strut Apposition by Optical Coherence Tomography. REVISTA ESPANOLA DE CARDIOLOGIA. 63:904-914. DOI.
  • Godino C; Al-Lamee R; La Rosa C; Morici N; Latib A; Ielasi A; Di Mario C; Sangiorgi GM; et alColombo A. (1 Aug 2010). Coronary Left Main and Non-Left Main Bifurcation Angles: How are the Angles Modified by Different Bifurcation Stenting Techniques?. JOURNAL OF INTERVENTIONAL CARDIOLOGY. 23:382-393. DOI.
  • Di Mario C; Zamorano J. (Aug 2010). Hand and brain: interventional cardiology and echocardiography. EuroIntervention. 6:309-312. DOI.
  • Wykrzykowska JJ; Garg S; Girasis C; de Vries T; Morel M-A; van Es G-A; Buszman P; Linke A; et alIschinger T; Klauss V; Corti R; Eberli F; Wijns W; Morice M-C; di Mario C; van Geuns RJ; Juni P; Windecker S; Serruys PW. (20 Jul 2010). Value of the SYNTAX Score for Risk Assessment in the All-Comers Population of the Randomized Multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) Trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 56:272-277. Author weblink DOI.
  • Borgia F; Goodman SG; Halvorsen S; Cantor WJ; Piscione F; Le May MR; Fernández-Avilés F; Sánchez PL; et alDimopoulos K; Scheller B; Armstrong PW; Di Mario C. (Sep 2010). Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis. Eur Heart J. 31:2156-2169. DOI.
  • Di Mario C. (1 Jun 2010). Many breeds are better than a workhorse. Catheter Cardiovasc Interv. 75:1074-1075. DOI.
  • Di Mario C; James S; Ludman P; Windecker S; Sabate M. (Jun 2010). Scientific societies and clinical trials. EuroIntervention. 6:185-188.
  • Tyczynski P; Moreno-Ambroj C; Pugliese F; Kukreja N; Pieri E; Katoh O; Di Mario C. (1 May 2010). Successful percutaneous opening of chronic total occlusion of the right coronary artery originating from the right sinus common coronary trunk. J Cardiovasc Med (Hagerstown). DOI.
  • Tyczynski P; Kukreja N; van Geuns RJ; Wykrzykowska JJ; Sheppard MN; Di Mario C. (May 2010). Optical coherence tomography for the assessment of pericardium covered stents for the treatment of degenerated saphenous vein grafts. EuroIntervention. 6:78-85.
  • Di Mario C; Pugliese F. (May 2010). To whom does cardiac MSCT belong?. EuroIntervention. 6:29-33.
  • Di Mario C. (Apr 2010). Why so few women in interventional cardiology?. EuroIntervention. 5:883-887.
  • Secco GG; Di Mario C. (19 Mar 2010). A new dedicated ultrashort steerable balloon for side branch ostial dilatation. Catheter Cardiovasc Interv. DOI.
  • Sarno G; Garg S; Onuma Y; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; et alCorti R; Wijns W; Morice M-C; di Mario C; van Geuns RJ; Eerdmans P; Garcia-Garcia HM; van Es G-A; Goedhart D; de Vries T; Jueni P; Meier B; Windecker S; Serruys P. (15 Feb 2010). The Impact of Body Mass Index on the One Year Outcomes of Patients Treated by Percutaneous Coronary Intervention With Biolimus- and Sirolimus-Eluting Stents (from the LEADERS Trial). AMERICAN JOURNAL OF CARDIOLOGY. 105:475-479. Author weblink DOI.
  • Di Mario C. (Feb 2010). Minutes and handbooks. EuroIntervention. 5:769-772.
  • Prati F; Regar E; Mintz GS; Arbustini E; Di Mario C; Jang I-K; Akasaka T; Costa M; et alGuagliumi G; Grube E; Ozaki Y; Pinto F; Serruys PWJ. (1 Feb 2010). Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. EUROPEAN HEART JOURNAL. 31:401-415. DOI.
  • Barlis P; Regar E; Serruys PW; Dimopoulos K; van der Giessen WJ; van Geuns RJ; Ferrante G; Wandel S; et alWindecker S; van Es GA; Eerdmans P; Jüni P; di Mario C. (Jan 2010). An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study. Eur Heart J. 31:165-176. DOI.
  • Di Mario C; Piepoli MF. (Jan 2010). "Rehabilitation" after PCI: nonsense or the only way to achieve lasting results?. EuroIntervention. 5:655-658.
  • Bucciarelli-Ducci C; Di Mario C; Pennell DJ. (29 Dec 2009). Perfusion Cardiovascular Magnetic Resonance in the Clinical Scenario of Patients With Coronary Artery Disease. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 55:78-79. Author weblink DOI.
  • Di Mario C; Parisi R. (Nov 2009). Floating stenting: yet another technique of bifurcational stenting?. Rev Esp Cardiol. 62:1221-1223.
  • Tyczynski P; Ferrante G; Kukreja N; Moreno-Ambroj C; Barlis P; Ramasami N; De Silva R; Beatt K; et alDi Mario C. (Nov 2009). Optical coherence tomography assessment of a new dedicated bifurcation stent. EuroIntervention. 5:544-551.
  • Di Mario C. (Nov 2009). Interventional cardiologists: a new breed?. EuroIntervention. 5:535-537.
  • Kimura M; Katoh O; Tsuchikane E; Nasu K; Kinoshita Y; Ehara M; Terashima M; Matsuo H; et alMatsubara T; Asakura K; Asakura Y; Nakamura S; Oida A; Takase S; Reifart N; Di Mario C; Suzuki T. (1 Nov 2009). The Efficacy of a Bilateral Approach for Treating Lesions With Chronic Total Occlusions The CART (Controlled Antegrade and Retrograde subintimal Tracking) Registry. JACC-CARDIOVASCULAR INTERVENTIONS. 2:1135-1141. DOI.
  • Tyczynski P; Witkowski A; Kukreja N; Barlis P; Pieri E; Di Mario C. (1 Sep 2009). A glimpse into the coronary applications of optical coherence tomography. POSTEPY W KARDIOLOGII INTERWENCYJNEJ. 5:148-157. Author weblink.
  • Di Mario C. (Sep 2009). Informed consent in interventional cardiology. EuroIntervention. 5:415-416.
  • Wykrzykowska JJ; Serruys PW; Onuma Y; de Vries T; van Es G-A; Buszman P; Linke A; Ischinger T; et alKlauss V; Corti R; Eberli F; Wijns W; Morice M-C; di Mario C; van Geuns RJ; Juni P; Windecker S. (1 Sep 2009). Impact of Vessel Size on Angiographic and Clinical Outcomes of Revascularization With Biolimus-Eluting Stent With Biodegradable Polymer and Sirolimus-Eluting Stent With Durable Polymer The LEADERS Trial Substudy. JACC-CARDIOVASCULAR INTERVENTIONS. 2:861-870. DOI.
  • Barlis P; Sianos G; Ferrante G; Del Furia F; D'Souza S; Di Mario C. (24 Jul 2009). The use of intra-coronary optical coherence tomography for the assessment of sirolimus-eluting stent fracture. Int J Cardiol. 136:e16-e20. DOI.
  • Aguiar-Souto P; Barlis P; Di Mario C. (1 Jul 2009). Optical Coherence Tomography. Ancient Topics, Modern Perspectives. REVISTA ESPANOLA DE CARDIOLOGIA. 62:806-806. Author weblink DOI.
  • Tyczynski P; Kukreja N; Pieri E; di Mario C. (14 Apr 2011). Optical frequency domain imaging guided crossing of a stumpless chronic total occlusion. Int J Cardiol. 148:231-233. DOI.
  • Di Mario C. (1 Jun 2009). Ars Longa, Vita Brevis. JACC-CARDIOVASCULAR INTERVENTIONS. 2:487-488. DOI.
  • Tanigawa J; Barlis P; Dimopoulos K; Dalby M; Moore P; Di Mario C. (15 May 2009). The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography. INTERNATIONAL JOURNAL OF CARDIOLOGY. 134:180-188. Author weblink DOI.
  • Giannakoulas G; Dimopoulos K; Engel R; Goktekin O; Kucukdurmaz Z; Vatankulu MA; Bedard E; Diller GP; et alPapaphylactou M; Francis DP; Di Mario C; Gatzoulis MA. (15 May 2009). Burden of Coronary Artery Disease in Adults With Congenital Heart Disease and Its Relation to Congenital and Traditional Heart Risk Factors. AMERICAN JOURNAL OF CARDIOLOGY. 103:1445-1450. Author weblink DOI.
  • Moore P; Barlis P; Spiro J; Ghimire G; Roughton M; Di Mario C; Wallis W; Ilsley C; et alMitchell A; Mason M; Kharbanda R; Vincent P; Sherwin S; Dalby M. (May 2009). A randomized optical coherence tomography study of coronary stent strut coverage and luminal protrusion with rapamycin-eluting stents. JACC Cardiovasc Interv. 2:437-444. DOI.
  • Waksman R; Erbel R; Di Mario C; Bartunek J; de Bruyne B; Eberli FR; Erne P; Haude M; et alHorrigan M; Ilsley C; Boese D; Bonnier H; Koolen J; Luescher TF; Weissman NJ. (1 Apr 2009). Early- and Long-Term Intravascular Ultrasound and Angiographic Findings After Bioabsorbable Magnesium Stent Implantation in Human Coronary Arteries. JACC-CARDIOVASCULAR INTERVENTIONS. 2:312-320. DOI.
  • Nicol ED; Schultz C; Stirrup J; Roughton M; Padley SP; Rubens MB; Davies SW; Di Mario C. (8 Oct 2010). Defining the appropriate CTA stenosis threshold for gatekeeping to invasive angiography: 50% or 70%?. Int J Cardiol. 144:297-298. DOI.
  • Barlis P; Di Mario C. (20 Mar 2009). Retrograde approach to recanalising coronary chronic total occlusions immediately following a failed conventional attempt. INTERNATIONAL JOURNAL OF CARDIOLOGY. 133:E14-E17. Author weblink DOI.
  • Barlis P; Dimopoulos K; Tanigawa J; Dzielicka E; Ferrante G; Del Furia F; Di Mario C. (28 May 2010). Quantitative analysis of intracoronary optical coherence tomography measurements of stent strut apposition and tissue coverage. Int J Cardiol. 141:151-156. DOI.
  • Ghimire G; Spiro J; Kharbanda R; Roughton M; Barlis P; Mason M; Ilsley C; Di Mario C; et alErbel R; Waksman R; Dalby M. (Jan 2009). Initial evidence for the return of coronary vasoreactivity following the absorption of bioabsorbable magnesium alloy coronary stents. EuroIntervention. 4:481-484.
  • Ferrante G; Kaplan AV; Di Mario C. (1 Jan 2009). Assessment With Optical Coherence Tomography of a New Strategy for Bifurcational Lesion Treatment: The Tryton Side-Branch Stent. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. 73:69-72. Author weblink DOI.
  • Taglieri N; Di Mario C. (2009). Percutaneous coronary intervention following thrombolysis: for whom and when?. Acute Card Care. 11:195-203. DOI.
  • Aguiar-Souto P; Ferrante G; Del Furia F; Barlis P; Khurana R; Di Mario C. (18 Feb 2010). Frequency and predictors of contrast-induced nephropathy after angioplasty for chronic total occlusions. Int J Cardiol. 139:68-74. DOI.
  • Barlis P; Dimopoulos K; Di Mario C. (28 Oct 2008). Letter by Barlis et al Regarding Article, "Two-Year Clinical Outcomes With Drug-Eluting Stents for Diabetic Patients With De Novo Coronary Lesions: Results From a Real-World Multicenter Registry. CIRCULATION. 118:E679-E679. Author weblink DOI.
  • Godino C; Furuichi S; Latib A; Morici N; Chieffo A; Romagnoli E; Tamburino C; Barbagallo R; et alCera M; Antoniucci D; Goktekin O; Di Mario C; Reimers B; Grube E; Airoldi F; Sangiorgi GM; Colombo A. (15 Oct 2008). Clinical and Angiographic Follow-Up of Small Vessel Lesions Treated With Paclitaxel-Eluting Stents (from the TRUE Registry). AMERICAN JOURNAL OF CARDIOLOGY. 102:1002-1008. Author weblink DOI.
  • Di Mario C; Ramasami N. (1 Oct 2008). Techniques to Enhance Guide Catheter Support. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. 72:505-512. Author weblink DOI.
  • Chevalier B; Di Mario C; Neumann F-J; Ribichini F; Urban P; Popma JJ; Fitzgerald PJ; Cutlip DE; et alWilliams DO; Ormiston J; Grube E; Whitbourn R; Schwartz LB. (1 Oct 2008). A Randomized, Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of Zotarolimus-Versus Paclitaxel-Eluting Stents in De Novo Occlusive Lesions in Coronary Arteries The ZoMaxx I Trial. JACC-CARDIOVASCULAR INTERVENTIONS. 1:524-532. Author weblink DOI.
  • Windecker S; Serruys PW; Wandel S; Buszman P; Trznadel S; Linke A; Lenk K; Ischinger T; et alKlauss V; Eberli F; Corti R; Wijns W; Morice MC; di Mario C; Davies S; van Geuns R-J; Eerdmans P; van Es G-A; Meier B; Jueni P. (1 Sep 2008). Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial. LANCET. 372:1163-1173. Author weblink DOI.
  • Barlis P; Ferrante G; Del Furia F; Di Mario C. (16 Jun 2008). In-vivo characterisation of coronary atherosclerosis with optical coherence tomography. Med J Aust. 188:728.
  • Di Mario C; Piscione F; Gaspardone A; Bolognese L; Steg G. (14 Jun 2008). CARESS-in-AMI study - Reply. LANCET. 371:1998-1998. Author weblink.
  • Di Mario C; Ferrante G. (1 Jun 2008). Embolization The "Dark Side" of Percutaneous Coronary Interventions. JACC-CARDIOVASCULAR INTERVENTIONS. 1:277-278. DOI.
  • Dimopoulos K; Di Mario C; Barlis P; Pennell D; Goktekin O; Kaddoura S; Gatzoulis MA. (23 May 2008). Haemodynamic significance of an anomalous right coronary with inter-arterial course assessed with intracoronary pressure measurements during dobutamine challenge. Int J Cardiol. 126:e32-e35. DOI.
  • Barlis P; Kaplan S; Dimopoulos K; Tanigawa J; Schultz C; Di Mario C. (1 Apr 2008). An indeterminate occlusion duration predicts procedural failure in the recanalization of coronary chronic total occlusions. Catheter Cardiovasc Interv. 71:621-628. DOI.
  • Di Mario C; Barlis P. (1 Apr 2008). Optical Coherence Tomography A New Tool to Detect Tissue Coverage in Drug-Eluting Stents. JACC-CARDIOVASCULAR INTERVENTIONS. 1:174-175. Author weblink DOI.
  • Di Mario C; Ferrante G. (15 Mar 2008). Biodegradable drug-eluting stents: promises and pitfalls. Lancet. 371:873-874. DOI.
  • Tanigawa J; Barlis P; Dimopoulos K; Di Mario C. (Mar 2008). Optical coherence tomography to assess malapposition in overlapping drug-eluting stents. EuroIntervention. 3:580-583.
  • Di Mario C; Dudek D; Piscione F; Mielecki W; Savonitto S; Murena E; Dimopoulos K; Manari A; et alGaspardone A; Ochala A; Zmudka K; Bolognese L; Steg PG; Flather M; CARESS-in-AMI (Combined Abciximab RE-teplase Stent Study in Acute Myocardial Infarction) Investigators. (16 Feb 2008). Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial. Lancet. 371:559-568. DOI.
  • Kaplan S; Barlis P; Tanigawa J; Goktekin O; Di Mario C. (1 Feb 2008). Unconventional treatment of aorto-ostial instent restenosis with marked protrusion into the aorta. JOURNAL OF CARDIOVASCULAR MEDICINE. 9:184-186. Author weblink.
  • Barlis P; Kaplan S; Dimopoulos K; Ferrante G; Di Mario C. (2008). Comparison of bare-metal and sirolimus- or paclitaxel-eluting stents for aorto-ostial coronary disease. Cardiology. 111:270-276. DOI.
  • Tanigawa J; Barlis P; Di Mario C. (Jan 2008). Heavily calcified coronary lesions preclude strut apposition despite high pressure balloon dilatation and rotational atherectomy: in-vivo demonstration with optical coherence tomography. Circ J. 72:157-160.
  • Kaplan S; Barlis P; Kiris A; Dimopoulos K; Celik S; Di Mario C. (2008). Immediate procedural and long-term clinical outcomes following drug-eluting stent implantation to ostial saphenous vein graft lesions. Acute Card Care. 10:88-92. DOI.
  • Azzarelli S; Amico F; Giacoppo M; Argentino V; Di Mario C; Fiscella A. (Nov 2007). Primary coronary angioplasty in a patient with anomalous origin of the right coronary artery from the left sinus of Valsalva. J Cardiovasc Med (Hagerstown). 8:943-945. DOI.
  • Barlis P; Tanigawa J; Di Mario C. (1 Oct 2007). Coronary bioabsorbable magnesium stent: 15-month intravascular ultrasound and optical coherence tomography findings. EUROPEAN HEART JOURNAL. 28:2319-2319. Author weblink DOI.
  • Barlis P; Di Mario C. (14 Sep 2007). Still a future for the bare metal stent?. INTERNATIONAL JOURNAL OF CARDIOLOGY. 121:1-3. Author weblink DOI.
  • di Mario C; Dimopoulos K. (7 Aug 2007). The effect of drug-eluting stents on collateral coronary flow. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 50:560-560. Author weblink DOI.
  • Kaplan S; Dimopoulos K; La Manna A; Goktekin O; Galassi A; Tanigwa J; Di Mario C. (1 Aug 2007). Culotte versus T-stenting in bifurcation lesions: Immediate clinical and angiographic results and midterm clinical follow-up. AMERICAN HEART JOURNAL. 154:336-343. Author weblink DOI.
  • Di Mario C; Barlis P; Tanigawa J; Locca D; Bucciarelli-Ducci C; Kaplan S; Katoh O. (Aug 2007). Retrograde approach to coronary chronic total occlusions: preliminary single European centre experience. EuroIntervention. 3:181-187.
  • Barlis P; Virmani R; Sheppard MN; Tanigawa J; Di Mario C. (1 Jul 2007). Angiographic and histological assessment of successfully treated late acute stent thrombosis secondary to a sirolimus-eluting stent. EUROPEAN HEART JOURNAL. 28:1675-1675. Author weblink DOI.
  • Erbel R; Di Mario C; Bartunek J; Bonnier J; de Bruyne B; Eberli FR; Erne P; Haude M; et alHeublein B; Horrigan M; Ilsley C; Boese D; Koolen J; Luescher TF; Weissman N; Waksman R. (2 Jun 2007). Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial. LANCET. 369:1869-1875. Author weblink DOI.
  • Barlis P; Tanigawa J; Di Mario C. (Jun 2007). Successful crossing of an angulated lesion using a new deflectable-tip guidewire (Steer-IT). J Invasive Cardiol. 19:E154-E155.
  • La Manna A; Locca DA; Prasad SK; Di Mario C. (29 May 2007). Loculated pericardial hematoma complicating complex coronary interventions - A rare but often missed diagnosis?. CIRCULATION. 115:E540-E541. Author weblink DOI.
  • La Manna A; Locca DA; Prasad SK; Di Mario C. (29 May 2007). Images in cardiovascular medicine. Loculated pericardial hematoma complicating complex coronary interventions: a rare but often missed diagnosis?. Circulation. 115:e540-e541. DOI.
  • Biondi-Zoccai GGL; Sangiorgi GM; Antoniucci D; Grube E; Di Mario C; Reimers B; Tamburino C; Agostoni P; et alCosgrave J; Colombo A. (2 May 2007). Testing prospectively the effectiveness and safety of paclitaxel-eluting stents in over 1000 very high-risk patients - Design, baseline characteristics, procedural data and in-hospital outcomes of the multicenter Taxus in Real-life Usage Evaluation (TRUE) Study. INTERNATIONAL JOURNAL OF CARDIOLOGY. 117:349-354. Author weblink DOI.
  • Di Mario C; Werner GS; Sianos G; Galassi AR; Büttner J; Dudek D; Chevalier B; Lefevre T; et alSchofer J; Koolen J; Sievert H; Reimers B; Fajadet J; Colombo A; Gershlick A; Serruys PW; Reifart N. (May 2007). European perspective in the recanalisation of Chronic Total Occlusions (CTO): consensus document from the EuroCTO Club. EuroIntervention. 3:30-43.
  • Tanigawa J; Barlis P; Di Mario C. (May 2007). Intravascular optical coherence tomography: optimisation of image acquisition and quantitative assessment of stent strut apposition. EuroIntervention. 3:128-136.
  • Di Mario C; Morici N; Godino C; Goktekin O; Tamburino C; Barbagallo R; Antoniucci D; Grube E; et alAiroldi F; Zoccai GB; Colombo A; Sangiorgi GM. (15 Feb 2007). Predictors of restenosis after treatment of bifurcational lesions with paclitaxel eluting stents: A multicenter prospective registry of 150 consecutive patients. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. 69:416-424. Author weblink DOI.
  • Goktekin O; Kaplan S; Dimopoulos K; Barlis P; Tanigawa J; Vatankulu MA; Koning G; Tuinenburg JC; et alDi Mario C. (1 Feb 2007). A new quantitative analysis system for the evaluation of coronary bifurcation lesions: Comparison with current conventional methods. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. 69:172-180. Author weblink DOI.
  • Tanigawa J; Petrou M; Di Mario C. (31 Jan 2007). Selective injection of the conus branch should always be attempted if no collateral filling visualises a chronically occluded left anterior descending coronary artery. Int J Cardiol. 115:126-127. DOI.
  • Musto C; Simon P; Nicol E; Tanigawa J; Davies SW; Oldershaw PJ; Arcuri N; Fox K; et alDi Mario C. (2 Jan 2007). 64-multislice computed tomography in consecutive patients with suspected or proven coronary artery disease: initial single center experience. Int J Cardiol. 114:90-97. DOI.
  • Barlis P; Tanigawa J; Kaplan S; di Mario C. (Dec 2006). Complex coronary interventions: unprotected left main and bifurcation lesions. J Interv Cardiol. 19:510-524. DOI.
  • Bhatia VK; Di Mario C. (Aug 2006). Darwin and the survival of the fittest in modern interventional cardiology. Heart. 92:1017-1018. DOI.
  • La Manna A; Goktekin O; Fiscella D; Dalby M; Tanigawa J; Fiscella A; Tamburino C; Di Mario C. (Jun 2006). Which strategy should be used for acute ST-elevation myocardial infarction in patients aged more than 75 years?. J Cardiovasc Med (Hagerstown). 7:388-396. DOI.
  • Di Mario C; Di Sciascio G; Dubois-Randé JL; Michels R; Mills P. (May 2006). Curriculum and syllabus for Interventional Cardiology subspecialty training in Europe. EuroIntervention. 2:31-36.
  • Biondi-Zoccai GGL; Agostoni P; Sangiorgi GM; Iakovou I; Antoniucci D; Grube E; Tamburino C; Di Mario C; et alReimers B; Michev L; Goktekin O; Airoldi F; Chieffo A; Cosgrave J; Tassanawiwat W; Colombo A. (14 Apr 2006). Comparison of ticlopidine vs. clopidogrel in addition to aspirin after paclitaxel-eluting stent implantation: Insights from the TRUE (Taxus (TM) in Real-life Usage Evaluation) Study. INTERNATIONAL JOURNAL OF CARDIOLOGY. 108:406-407. Author weblink DOI.
  • Rajagopal R; Musto C; La Manna A; Tanigawa J; Goktekin O; Di Mario C. (Oct 2005). Thrombectomy and distal protection devices. Minerva Cardioangiol. 53:415-430.
  • Di Mario C; Lafont A. (Aug 2005). Training in interventional cardiology in Europe: how to move from chaos to rational common programmes?. EuroIntervention. 1:135-137.
  • Ostermayer SH; Reisman M; Kramer PH; Matthews RV; Gray WA; Block PC; Omran H; Bartorelli AL; et alDella Bella P; Di Mario C; Pappone C; Casale PN; Moses JW; Poppas A; Williams DO; Meier B; Skanes A; Teirstein PS; Lesh MD; Nakai T; Bayard Y; Billinger K; Trepels T; Krumsdorf U; Sievert H. (5 Jul 2005). Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation - Results from the international multi-center feasibility trials. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 46:9-14. Author weblink DOI.
  • Di Mario C; Sutaria N. (Jul 2005). Coronary angiography in the angioplasty era: projections with a meaning. Heart. 91:968-976. DOI.
  • Webb CM; Collins P; Di Mario C. (Feb 2005). Normal coronary physiology assessed by intracoronary Doppler ultrasound. Herz. 30:8-16. DOI.
  • Di Mario C; Griffiths H; Goktekin O; Peeters N; Verbist J; Bosiers M; Deloose K; Heublein B; et alRohde R; Kasese V; Ilsley C; Erbel R. (Dec 2004). Drug-eluting bioabsorbable magnesium stent. J Interv Cardiol. 17:391-395. DOI.
  • Griffiths H; Bakhai A; West D; Petrou M; De Souza T; Moat N; Pepper J; Di Mario C. (Sep 2004). Feasibility and cost of treatment with drug eluting stents of surgical candidates with multi-vessel coronary disease. Eur J Cardiothorac Surg. 26:528-534. DOI.
  • Mikhail GW; Airoldi F; Tavano D; Chieffo A; Rogacka R; Carlino M; Montorfano M; Sangiorgi G; et alCorvaja N; Michev I; Orlic D; Di Mario C; Colombo A. (1 Sep 2004). The use of drug eluting stents in single and multivessel disease: results from a single centre experience. HEART. 90:990-994. Author weblink DOI.
  • Di Mario C; Mikhail G. (Sep 2004). Treating multivessel disease in the era of coated stents: introduction. Heart. 90:989.
  • Di Mario C; Griffiths H. (Sep 2004). Treating multivessel disease in the era of coated stents: conclusion. Heart. 90:1003. DOI.
  • Di Mario C; Bolognese L; Maillard L; Dudek D; Gambarati G; Manari A; Guiducci V; Patrizi G; et alRusconi LC; Piovaccari G; Hibon AR; Belpomme V; Indolfi C; Olivari Z; Steffenino G; Zmudka K; Airoldi F; Panzarasa R; Flather M; Steg PG. (Sep 2004). Combined Abciximab REteplase Stent Study in acute myocardial infarction (CARESS in AMI). Am Heart J. 148:378-385. DOI.
  • Di Mario C; Griffiths H; O'Rourke B; Kaddoura S. (1 Jun 2004). The impact of Sirolimus Eluting stents in interventional cardiology. INTERNATIONAL JOURNAL OF CARDIOLOGY. 95:117-121. Author weblink DOI.
  • Di Mario C; Grube E; Nisanci Y; Reifart N; Colombo A; Rodermann J; Muller R; Umman S; et alLiistro F; Montorfano M; Alt E. (1 Jun 2004). MOONLIGHT: a controlled registry of an iridium oxide-coated stent with angiographic follow-up. INTERNATIONAL JOURNAL OF CARDIOLOGY. 95:329-331. Author weblink DOI.
  • Di Mario C; Mara S; Flavio A; Imad S; Antonio M; Anna P; Emanuela P; Stefano DS; et alAngelo R; Stefania C; Anna F; Carmelo C; Antonio C; Monzini N; Bonardi MA. (2004). Single vs multivessel treatment during primary angioplasty: results of the multicentre randomised HEpacoat for cuLPrit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) Study. Int J Cardiovasc Intervent. 6:128-133. DOI.
  • Liistro F; Di Mario C. (1 Aug 2003). Carotid artery stenting. HEART. 89:944-948. Author weblink DOI.

Books

  • Mario CD; Dangas G; Barlis P. Interventional Cardiology. . Wiley-Blackwell (24 May 2011).

Conferences

  • Chan PH; Di Mario C; Davies SW; Kelleher A; Trimlett R; Moat N. Outcome comparison of non-transfemoral approaches for transcatheter aortic valve implantation utilizing CoreValve. 23rd Annual Transcatheter Cardiovascular Therapeutics (TCT) Symposium, 7 Nov 2011 - 11 Nov 2011. 58:B200-B200. ELSEVIER SCIENCE INC (8 Nov 2011). Author weblink.
  • Gutierrez-Chico JL; Raber L; Regar E; Okamura T; di Mario C; Windecker S; van Es G-A; Serruys PW. Tissue coverage and neointimal hyperplasia of overlap vs. non-overlap segments in drug-eluting stents 9-13 months after implantation: in vivo-assessment with optical coherence tomography. 23rd Annual Transcatheter Cardiovascular Therapeutics (TCT) Symposium, 7 Nov 2011 - 11 Nov 2011. 58:B168-B168. ELSEVIER SCIENCE INC (8 Nov 2011). Author weblink.
  • Navarese EP; Kubica J; De Sarvi S; Gibson CM; Di Mario C; Andreotti F; Margheri M; Bolognese L; et alCasaiota F. Safety and Efficacy of Biodegradable vs Durable Polymer Drug Eluting Stents: Evidence from a Meta-analysis of Randomized Trials. 23rd Annual Transcatheter Cardiovascular Therapeutics (TCT) Symposium, 7 Nov 2011 - 11 Nov 2011. 58:B98-B98. ELSEVIER SCIENCE INC (8 Nov 2011). Author weblink.
  • Foin N; Secco G; Sen S; Davies JE; Krams R; Di Mario C. Bench Micro-CT study and OCT Experience of a Final Proximal Post-dilatation to Optimize Results in Bifurcation Stenting. 23rd Annual Transcatheter Cardiovascular Therapeutics (TCT) Symposium, 7 Nov 2011 - 11 Nov 2011. 58:B87-B87. ELSEVIER SCIENCE INC (8 Nov 2011). Author weblink.
  • Foin N; Di Mario C; Jain AK. Treatment of bifurcations with the dedicated Sideguard nitinol stent compared with conventional 2-stent strategies. 23rd Annual Transcatheter Cardiovascular Therapeutics (TCT) Symposium, 7 Nov 2011 - 11 Nov 2011. 58:B85-B85. ELSEVIER SCIENCE INC (8 Nov 2011). Author weblink.
  • Foin N; Torii R; Mortier P; De Beule M; Viceconte N; Davies JE; Xu XY; Krams R; et alDi Mario C. Sequential Side Branch and Main Vessel Dilatation instead of Kissing Balloon after Provisional Bifurcation Stenting: Lessons from Micro-CT and Computational Simulations. 23rd Annual Transcatheter Cardiovascular Therapeutics (TCT) Symposium, 7 Nov 2011 - 11 Nov 2011. 58:B82-B82. ELSEVIER SCIENCE INC (8 Nov 2011). Author weblink.
  • Foin N; Secco G; Ghilencea L; Krams R; Di Mario C. FINAL PROXIMAL POST-DILATATION IS NECESSARY AFTER KISSING BALLOON IN BIFURCATIONS STENTING. 60th Annual Scientific Session and Expo of the American-College-of-Cardiology, 3 Apr 2011 - 5 Apr 2011. 57:E1721-E1721. ELSEVIER SCIENCE INC (5 Apr 2011).
  • Bucciarelli-Ducci C; Locca D; O'Hanlon R; Petryka J; Grasso A; Ferrante G; Symmonds K; Wage R; et alAsimacopoulos E; Gatehouse P; Prasad S; Di Mario C; Pennell D. Recanalization of Coronary Chronic Total Occlusion Guided by Left Ventricular Function, Perfusion and Viability Imaging by Cardiovascular Magnetic Resonance. 82nd Scientific Session of the American-Heart-Association, 14 Nov 2009 - 18 Nov 2009. 120:S975-S975. LIPPINCOTT WILLIAMS & WILKINS (3 Nov 2009). Author weblink.
  • Moreno-Ambroj C; Kukreja N; Tyczynski P; Ali O; Pieri E; Ferrante G; Barlis P; Aguiar-Souto P; et alDi Mario C. Percutaneous Treatment Of Chronic Total Occlusions: Results From the Analysis Of a 313 Patient Registry. 21st Annual Transcatheter Cardiovascular Therapeutics Conference, 21 Sep 2009 - 25 Sep 2009. 104:93D-93D. EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC (21 Sep 2009). Author weblink.
  • Tyczynski P; Ferrante G; Moreno-Ambroj C; Kukreja N; Barlis P; Pieri E; de Silva R; Di Mario C. Stent Strut Apposition In Coronary Bifurcation Lesions Assessed With Optical Coherence Tomography: One Stent Vs Two Stent (Culotte) Strategy. 21st Annual Transcatheter Cardiovascular Therapeutics Conference, 21 Sep 2009 - 25 Sep 2009. 104:41D-41D. EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC (21 Sep 2009). Author weblink.
  • Wykrzykowska JJ; Raeber L; de Vries T; Bressers M; Buszman P; Linke A; Ischinger T; Klauss V; et alEberli F; Corti R; Wijns W; Morice M-C; di Mario C; Regar E; Juni P; Windecker S; Serruys PW. Biolimus-eluting Biodegradable Polymer Versus Sirolimus-eluting Permanent Polymer Stent Performance In Long Lesions. Results From The LEADERS Multicenter Trial Substudy. 21st Annual Transcatheter Cardiovascular Therapeutics Conference, 21 Sep 2009 - 25 Sep 2009. 104:135D-136D. EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC (21 Sep 2009). Author weblink.
  • Moreno-Ambroj C; Kukreja N; Tyczynski P; Pieri E; Ferrante G; Barlis P; Galache-Osuna JG; Ali O; et alDi Mario C. Predictors Of Success and Failure In the Treatment Of Chronic Total Occlusions. 21st Annual Transcatheter Cardiovascular Therapeutics Conference, 21 Sep 2009 - 25 Sep 2009. 104:95D-96D. EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC (21 Sep 2009). Author weblink.
  • Linke A; Lenk K; Serruys PW; van Es G-A; Buszman P; Ischinger T; Klauss V; Eberli F; et alCorti R; Wijns W; Morice M-C; di Mario C; Juni P; Schuler G; Windecker S. Impact of Diabetes on Angiographic And Clinical Outcomes of Revascularization With Biolimus-eluting Stent With Biodegradable Polymer and Sirolimus-eluting Stent With Durable Polymer. LEADERS Trial Substudy. 21st Annual Transcatheter Cardiovascular Therapeutics Conference, 21 Sep 2009 - 25 Sep 2009. 104:138D-138D. EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC (21 Sep 2009). Author weblink.
  • Locca D; Ferrrante G; Bucciarelli-Ducci C; Del Furia F; Barlis P; Grasso A; La Manna A; Prasad S; et alPennell D; Di Mario C. Balloon pre-dilatation in percutaneous coronary intervention. A cardiovascular magnetic resonance imaging and cardiac biomarker study of myocardial injury. 58th Annual Scientific Session of the American-College-of-Cardiology, 28 Mar 2009 - 31 Mar 2009. 53:A61-A61. ELSEVIER SCIENCE INC (10 Mar 2009). Author weblink.
  • Locca D; Buccharelli-Ducci C; Ferrante G; La Manna A; Keenan N; Grasso A; Barlis P; Delfuria F; et alPrasad S; Kaski J; Pennell D; Di Mario C. Myocardial Damage Following Complex Percutaneous Coronary Intervention, as Assessed by Cardiac Magnetic Resonance Imaging: Testing the Association Between Markers of Inflammation and Distal Coronary Embolization. 58th Annual Scientific Session of the American-College-of-Cardiology, 28 Mar 2009 - 31 Mar 2009. 53:A398-A398. ELSEVIER SCIENCE INC (10 Mar 2009). Author weblink.
  • Ferrante G; Ramasami N; Tyczynski P; Kukreja N; Aguiar-Souto P; Del Furia F; Barlis P; Beatt K; et alDi Mario C. Stent Strut Apposition in Coronary Bifurcation Lesions assessed with Optical Coherence Tomography. 58th Annual Scientific Session of the American-College-of-Cardiology, 28 Mar 2009 - 31 Mar 2009. 53:A78-A78. ELSEVIER SCIENCE INC (10 Mar 2009). Author weblink.
  • Locca D; Ferrante G; Bucciarelli-Ducci C; La Manna A; Grasso A; Prasad S; Barlis P; Pennell D; et alKaski JC; Di Mario C. Troponin I, High sensitive C-reactive protein and Neopterin in Percutaneous Coronary Interventions: insight from Cardiac Magnetic Resonance Imaging. 81st Annual Scientific Session of the American-Heart-Association, 8 Nov 2008 - 12 Nov 2008. 118:S1046-S1046. LIPPINCOTT WILLIAMS & WILKINS (28 Oct 2008). Author weblink.
  • Gerber RT; Romagnoli E; Godino C; Tamburino C; Di Mario C; Reimers B; Grube E; Antoniucci D; et alColombo A; Sangiorgi G. The "CTO-TRUE" Registry: Revasculization with PES in Chronic Total Occlusions from a European Multicentre Controlled Prospective Registry. 20th Annual Transcatheter Cardiovascular Therapeutics Conference, 12 Oct 2008 - 17 Oct 2008. 102:109I-109I. EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC (12 Oct 2008). Author weblink.
  • Barlis P; Regar E; Dimopoulos K; van der Giessen WJ; van Geuns R; van den Ent M; Sianos G; Gonzalo N; et alDevries A; Ligthart J; de Feyter P; Ferrante G; Davies SW; Foran J; Collinson J; Leatham E; Clague J; Serruys PW; di Mario C. A Randomized Optical Coherence Tomography Study of an Erodible versus Durable Polymer-Coated Limus-Eluting Stent. 20th Annual Transcatheter Cardiovascular Therapeutics Conference, 12 Oct 2008 - 17 Oct 2008. 102:15I-15I. EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC (12 Oct 2008). Author weblink.
  • Godino C; Parodi G; Latib A; Furuichi S; Barbagallo R; Tamburino C; Grube E; Di Mario C; et alReimers B; Antoniucci D; Chieffo A; Colombo A; Sangiorgi GM. Long term Follow-up following Paclitaxel-Eluting Stent Implantation for the Treatment of unprotected Left Main Coronary Artery Disease. A Multicenter Controlled Prospective Study Registry (TRUE registry). 20th Annual Transcatheter Cardiovascular Therapeutics Conference, 12 Oct 2008 - 17 Oct 2008. 102:87I-87I. EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC (12 Oct 2008). Author weblink.
  • Serruys PW; Windecker S; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; et alMorice M-C; Di Mario C. Leaders - A Randomized Comparison Of A Biolimus-A9 Eluting Stent With A Sirolimus-eluting Stent For Percutaneous Coronary Intervention. 12 Months Results. 20th Annual Transcatheter Cardiovascular Therapeutics Conference, 12 Oct 2008 - 17 Oct 2008. 102:160I-161I. EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC (12 Oct 2008). Author weblink.
  • Nicol ED; Schultz C; Roughton M; Padley SPG; Rubens MB; Di Mario C; Davies S. A low coronary calcium score does not exclude significant coronary stenoses in patients with intermediate to high likelihood of coronary artery disease: A 64-MDCT and invasive coronary angiography correlation. Annual Scientific Conference of the British-Cardiovascular-Society/British-Society-for-Cardiovascular-Research, 2 Jun 2008 - 4 Jun 2008. 94:A81-A82. B M J PUBLISHING GROUP (1 Jul 2008). Author weblink.
  • Ghimire G; Spiro J; Kharbanda R; Roughton M; Barlis P; Mason M; Ilsley C; Mitchell A; et alDi Mario C; Erbel R; Waksman R; Dalby M. Coronary artery vasomotion may be possible in segments previously treated with bioabsorbable magnesium alloy coronary stents. Annual Scientific Conference of the British-Cardiovascular-Society/British-Society-for-Cardiovascular-Research, 2 Jun 2008 - 4 Jun 2008. 94:A123-A123. B M J PUBLISHING GROUP (1 Jul 2008). Author weblink.
  • Ghimire G; Spiro JR; Kharbanda RK; Roughton M; Barlis P; Mason M; Ilsley C; Di Mario C; et alErbel R; Waksman R; Dalby MCD. Evidence for the return of coronary vasoreactivity following absorption of a bioabsorbable magnesium alloy coronary stent. 19th Annual Transcatheter Cardiovascular Therapeutics Symposium, 20 Oct 2007 - 25 Oct 2007. 100:146L-146L. EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC (20 Oct 2007). Author weblink.
  • Kaplan S; Barlis P; Kiris A; Dimopoulos K; Celik S; Di Mario C. Immediate procedural and long-term clinical outcomes after drug eluting stent implantation to ostial saphenous vein graft lesions. 19th Annual Transcatheter Cardiovascular Therapeutics Symposium. 100:103L-103L. (20 Oct 2007).
  • Sianos G; Reifart N; Galassi AR; Buttner J; Schofer J; Di Mario C. Retrograde recanalisation of chronically occluded coronary arteries. Initial multicenter experience. 19th Annual Transcatheter Cardiovascular Therapeutics Symposium. 100:16L-16L. (20 Oct 2007).
  • Waksman R; Erbel R; Bonnier H; Di Mario C; Wijns W; Weissman NJ. 12 month clinical outcomes post absorbable metal stent implantation in human coronary arteries results from the PROGRESS study. 19th Annual Transcatheter Cardiovascular Therapeutics Symposium, 20 Oct 2007 - 25 Oct 2007. 100:20L-20L. EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC (20 Oct 2007). Author weblink.
  • Waksman R; Erbel R; Bonnier H; Di Mario C; Wijns W; Weissman NJ. Long-term clinical and intravascular ultrasound findings post-absorbable metal stent implantation in human coronary arteries. 80th Annual Scientific Session of the American-Heart-Association. 116:776-776. (16 Oct 2007).
  • Tanigawa J; Barlis P; Dimopoulos K; Di Mario C. Stent strut apposition of cypher select and Taxus liberte: A prospective optical coherence tomography study. i2 Summit 2007 on Innovation in Intervention, 24 Mar 2007 - 27 Mar 2007. 49:35B-35B. ELSEVIER SCIENCE INC (6 Mar 2007). Author weblink.
  • Barlis P; Kaplan S; Dimopoulos K; Goktekin O; La Manna A; Tanigawa J; Di Mario C. Culotte versus T-stenting in bifurcation lesions: Immediate clinical and angiographic results and midterm clinical follow-up. i2 Summit 2007 on Innovation in Intervention. 49:20B-20B. (6 Mar 2007).
  • Tanigawa J; Barlis P; Kaplan S; Goktekin O; Di Mario C. Stent strut apposition in complex lesions using optical coherence tomography. 18th Annual Transcatheter Cardiovascular Therapeutics Symposium, 22 Oct 2006 - 27 Oct 2006. 98:97M-98M. EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC (22 Oct 2006). Author weblink.
  • Furuichi S; Godino C; Antoniucci D; Tamburino C; Grube E; Reimers B; Airoldi F; Zoccai GB; et alMorici N; Palloshi A; Di Mario C; Chieffo A; Colombo A; Sangiorgi GM. Short and long-term outcome of paclitaxel-eluting stent implantation for left main coronary artery disease: Insights from the TAXUS in real life usage evaluation (TRUE) registry. 18th Annual Transcatheter Cardiovascular Therapeutics Symposium. 98:143M-143M. (22 Oct 2006).
  • Godino C; Furuichi S; Morici N; Palloshi A; Tavano D; Aprigliano G; Tamburino C; Antoniucci D; et alGrube E; Reimers B; Airoldi F; Zoccai GB; Di Mario C; Colombo A; Sangiorgi GM. Paclitaxel-eluting stent for treatment of small vessel disease: Insights from the TRUE registry. 18th Annual Transcatheter Cardiovascular Therapeutics Symposium, 22 Oct 2006 - 27 Oct 2006. 98:166M-166M. EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC (22 Oct 2006). Author weblink.
  • Godino C; Morici N; Airoldi F; Barbagallo R; Tamburrino C; Colombo A; Sangiorgi GM; Di Mario C. Does stenting modify the angle between daughter branches of bifurcational lesions and do these changes affect clinical outcome?. World Congress of Cardiology. 27:922-923. (Aug 2006).
  • Goktekin O; Vatankulu MA; Kaya MG; Kaplan S; Dimopoulos K; Di Mario C; Gatzoulis M. Prevalence of coronary artery disease in the adult congenital heart disease population. World Congress of Cardiology. 27:404-404. (Aug 2006).
  • Morici N; Godino C; Goktekin O; Barbagallo R; Tamburrino C; Colombo A; Sangiorgi MG; Di Mario C. Bifurcational lesions treated with paclitaxel eluting stents: a substudy of the TRUE trial (TAXUS in real life usage evaluation). World Congress of Cardiology, 2 Sep 2006 - 6 Sep 2006. 27:921-922. OXFORD UNIV PRESS (1 Aug 2006). Author weblink.
  • Colombo A; Sangiorgi GM; Biondi-Zoccai G; Agostoni P; Antoniucci D; Tamburino C; Di Mario C; Reimers B; et alGoktekin O; Grube E; TRUE Study Investigators. Appraising paclitaxel-eluting stents in over 1000 very high-risk patients. Insights from the Taxus in real-life usage evalutation (TRUE) study. 78th Annual Scientific Session of the American-Heart-Association. 112:U801-U801. (25 Oct 2005).
  • Grube E; Zoccai GB; Sangiorgi G; Antoniucci D; Reimers B; Tamburino C; Di Mario C; Colombo A. Assessing the safety and effectiveness of Taxus in 183 patients with chronic total occlusions: Insights from the TRUE study. 17th Annual Transcatheter Cardiovascular Therapeutics Symposium, 17 Oct 2005 - 21 Oct 2005. 96:37H-38H. EXCERPTA MEDICA INC (17 Oct 2005).
  • Sangiorgi G; Agostoni P; Zoccai GB; Antoniucci D; Tamburino C; Reimers B; Di Mario C; Grube E; et alColombo A. Is paclitaxel-eluting stent a valid choice for diabetic patients? Insights from the TRUE study. 17th Annual Transcatheter Cardiovascular Therapeutics Symposium, 17 Oct 2005 - 21 Oct 2005. 96:136H-136H. EXCERPTA MEDICA INC (17 Oct 2005). Author weblink.
  • Colombo A; Sangiorgi G; Zoccai GB; Antoniucci D; Tamburino C; Di Mario C; Reimers B; Goktekin O; et alGrube E; TRUE Study Investigators. Appraising paclitaxel-eluting stents in over 1000 very high-risk patients. Insights from the Taxus in real-life usage evalutation (TRUE) study. 17th Annual Transcatheter Cardiovascular Therapeutics Symposium. 96:45H-45H. (17 Oct 2005).
  • Sangiorgi G; Agostoni P; Biondi-Zoccai G; Antoniucci D; Goktekin O; Di Mario C; Grube E; Colombo A. Low target lesion revascularisation after the taxus paclitaxel-eluting stent in small vessels - An analysis from the TRUE study. 27th Congress of the European-Society-of-Cardiology, 3 Sep 2005 - 7 Sep 2005. 26:703-703. OXFORD UNIV PRESS (1 Sep 2005). Author weblink.
  • Vitrella G; Sansa M; Bongo AS; Di Mario C; Rosso R; Verde A; Novelli E; Cernigliaro C. Target-vessel revascularisation among patients who received oral rapamicyn or placebo after bare- metal stent implantation - Eighteen-months clinical follow-up of the rapamune study. 27th Congress of the European-Society-of-Cardiology. 26:696-696. (Sep 2005).
  • Sangiorgi G; Agostoni P; Grube E; Antoniucci D; Tamburino C; Reimers B; Di Mario C; Colombo A. Different clinical impact of the Taxus paclitaxel-eluting stent in non-insulin-requiring vs. insulin-requiring diabetic patients. insights from the TRUE study. 27th Congress of the European-Society-of-Cardiology, 3 Sep 2005 - 7 Sep 2005. 26:116-116. OXFORD UNIV PRESS (1 Sep 2005). Author weblink.
  • Antoniucci D; Migliorini A; Sangiorgi G; Parodi G; Agostoni P; Di Mario C; Grube E; Colombo A; et alTaxus Rel-lif Usge Evn TRUE Study. Percutaneous treatment of left main coronary artery disease with taxus paclitaxel-eluting stent. An analysis of the TRUE study. 27th Congress of the European-Society-of-Cardiology. 26:407-408. (Sep 2005).
  • Agostoni P; Sangiorgi G; Antoniucci D; Tamburino C; Reimers B; Di Mario C; Grube E; Colombo A. Is paclitaxel-eluting stent a valid choice for diabetic patients?. 27th Congress of the European-Society-of-Cardiology, 3 Sep 2005 - 7 Sep 2005. 26:116-116. OXFORD UNIV PRESS (1 Sep 2005). Author weblink.
  • Sangiorgi GM; Colombo A; Biondi-Zoccai GGL; Antoniucci D; Reimers B; Tamburino C; Di Mario C; Grube E. Safety and effectiveness of paclitaxel-eluting stent implantation in over 1000 very high-risk patients - Insights from the true study. 27th Congress of the European-Society-of-Cardiology, 3 Sep 2005 - 7 Sep 2005. 26:706-706. OXFORD UNIV PRESS (1 Sep 2005). Author weblink.
  • Vitrella G; Sansa M; Bongo AS; Campi A; Verde A; Di Mario C; Colombo A; Cernigliaro C. Does oral rapamycin reduce intimal hyperplasia after dare metal stent implantation? In-stent volume measurements after intravascular ultrasound and computer-assisted three-dimensional reconstruction. ESC Congress 2004, 28 Aug 2004 - 1 Sep 2004. 25:241-241. W B SAUNDERS CO LTD (1 Aug 2004). Author weblink.
  • Griffiths H; Bakhai A; West D; De Souza A; Clague J; Davies S; Brookes C; Bishop A; et alPepper J; Di Mario C. Stents without restenosis: Enough to replace bypass surgery?. 54th Annual Scientific Session of the American-College-of-Cardiology. 43:98A-98A. (3 Mar 2004).
  • Griffiths H; Bakhai A; West D; de Souza A; Clague JR; Davies SW; Brookes CI; Bishop AJ; et alPepper J; Di Mario C. Stents without restenosis: Enough to replace bypass surgery?. 15th Annual Transcatheter Cardiovascular Therapeutics Symposium, 15 Sep 2003 - 19 Sep 2003. 92:59L-59L. EXCERPTA MEDICA INC (15 Sep 2003). Author weblink.
Share this on Delicious
Tweet this
Digg this
Stumble this
Share this on Facebook